SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001144204-17-057351
Filing Date
2017-11-08
Accepted
2017-11-08 18:02:09
Documents
1
Period of Report
2017-11-06

Document Format Files

Seq Description Document Type Size
1 FORM 4 tv478998_form4.html 4  
1 FORM 4 tv478998_form4.xml 4 3114
  Complete submission text file 0001144204-17-057351.txt   4654
Mailing Address 375 PARK AVE NEW YORK NY 10152
Business Address
ROSENWALD LINDSAY A MD (Reporting) CIK: 0000941841 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35366 | Film No.: 171187754

Mailing Address 2 GANSEVOORT STREET 9TH FLOOR NEW YORK NY 10014
Business Address 2 GANSEVOORT STREET 9TH FLOOR NEW YORK NY 10014 781-652-4500
Fortress Biotech, Inc. (Issuer) CIK: 0001429260 (see all company filings)

IRS No.: 205157386 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences